ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Program
Session
Number Needed to Treat and Associated Costs/Additional Responder of Dupilumab Versus Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Nov 19, 2024, 10:30 AM
«
1801
1802
1803
1804
1805
1806
1807
(current)
1808
1809
1810
»